The UK is rolling out expanded prostate cancer screening to thousands more black men, recognizing that this group faces significantly higher risks of developing the disease and dying from it. Health officials are extending the Transform trial, a targeted screening program designed to catch cases earlier when treatment is most effective.

This announcement reflects growing recognition that one-size-fits-all healthcare approaches can miss vulnerable populations. Black men in the UK have been shown to develop prostate cancer at younger ages and in more aggressive forms than other groups, yet have historically been underrepresented in screening programs. The expansion aims to close that gap through culturally informed outreach and tailored prevention strategies. Read the full story →

Today's takeaway: When health systems pay attention to who's being left behind, lives get saved.